vs
APOGEE ENTERPRISES, INC.（APOG）与Axsome Therapeutics, Inc.（AXSM）财务数据对比。点击上方公司名可切换其他公司
APOGEE ENTERPRISES, INC.的季度营收约是Axsome Therapeutics, Inc.的1.8倍（$351.4M vs $191.2M），Axsome Therapeutics, Inc.同比增速更快（57.4% vs 1.6%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs 2.9%）
Apogee Enterprises是一家美国音频设备制造商，主营音频接口、模数与数模转换器、USB及iOS麦克风，同时还开发音频制作相关软件，产品广泛服务于专业录音、音乐创作等音频领域，在全球音频行业拥有较高的认可度。
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
APOG vs AXSM — 直观对比
营收规模更大
APOG
是对方的1.8倍
$191.2M
营收增速更快
AXSM
高出55.8%
1.6%
两年增速更快
AXSM
近两年复合增速
2.9%
损益表 — Q4 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $351.4M | $191.2M |
| 净利润 | $16.6M | — |
| 毛利率 | 22.4% | — |
| 营业利润率 | 7.3% | -33.1% |
| 净利率 | 4.7% | — |
| 营收同比 | 1.6% | 57.4% |
| 净利润同比 | 568.8% | — |
| 每股收益（稀释后） | $0.78 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APOGAXSM
| Q1 26 | $351.4M | $191.2M | ||
| Q4 25 | $348.6M | $196.0M | ||
| Q3 25 | $358.2M | $171.0M | ||
| Q2 25 | $346.6M | $150.0M | ||
| Q1 25 | $345.7M | $121.5M | ||
| Q4 24 | $341.3M | $118.8M | ||
| Q3 24 | $342.4M | $104.8M | ||
| Q2 24 | $331.5M | $87.2M |
净利润APOGAXSM
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $-28.6M | ||
| Q3 25 | $23.6M | $-47.2M | ||
| Q2 25 | $-2.7M | $-48.0M | ||
| Q1 25 | $2.5M | $-59.4M | ||
| Q4 24 | $21.0M | $-74.9M | ||
| Q3 24 | $30.6M | $-64.6M | ||
| Q2 24 | $31.0M | $-79.3M |
毛利率APOGAXSM
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | 21.6% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | 29.8% | — |
营业利润率APOGAXSM
| Q1 26 | 7.3% | -33.1% | ||
| Q4 25 | 7.1% | -13.8% | ||
| Q3 25 | 7.5% | -27.0% | ||
| Q2 25 | 2.0% | -24.5% | ||
| Q1 25 | 1.8% | -46.9% | ||
| Q4 24 | 8.4% | -61.1% | ||
| Q3 24 | 12.3% | -59.8% | ||
| Q2 24 | 12.5% | -89.5% |
净利率APOGAXSM
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | -14.6% | ||
| Q3 25 | 6.6% | -27.6% | ||
| Q2 25 | -0.8% | -32.0% | ||
| Q1 25 | 0.7% | -48.9% | ||
| Q4 24 | 6.1% | -63.1% | ||
| Q3 24 | 8.9% | -61.7% | ||
| Q2 24 | 9.4% | -91.0% |
每股收益（稀释后）APOGAXSM
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $-0.55 | ||
| Q3 25 | $1.10 | $-0.94 | ||
| Q2 25 | $-0.13 | $-0.97 | ||
| Q1 25 | $0.12 | $-1.22 | ||
| Q4 24 | $0.96 | $-1.54 | ||
| Q3 24 | $1.40 | $-1.34 | ||
| Q2 24 | $1.41 | $-1.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.5M | $305.1M |
| 总债务越低越好 | $232.3M | $70.0M |
| 股东权益账面价值 | $511.8M | — |
| 总资产 | $1.1B | $713.6M |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资APOGAXSM
| Q1 26 | $39.5M | $305.1M | ||
| Q4 25 | $41.3M | $322.9M | ||
| Q3 25 | $39.5M | $325.3M | ||
| Q2 25 | $32.8M | $303.0M | ||
| Q1 25 | $41.4M | $300.9M | ||
| Q4 24 | $43.9M | $315.4M | ||
| Q3 24 | $51.0M | $327.3M | ||
| Q2 24 | $30.4M | $315.7M |
总债务APOGAXSM
| Q1 26 | $232.3M | $70.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $285.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益APOGAXSM
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $88.3M | ||
| Q3 25 | $500.2M | $73.7M | ||
| Q2 25 | $481.8M | $73.1M | ||
| Q1 25 | $487.9M | $53.2M | ||
| Q4 24 | $522.1M | $57.0M | ||
| Q3 24 | $506.4M | $92.9M | ||
| Q2 24 | $480.0M | $102.9M |
总资产APOGAXSM
| Q1 26 | $1.1B | $713.6M | ||
| Q4 25 | $1.1B | $689.8M | ||
| Q3 25 | $1.2B | $669.3M | ||
| Q2 25 | $1.2B | $639.8M | ||
| Q1 25 | $1.2B | $596.7M | ||
| Q4 24 | $1.2B | $568.5M | ||
| Q3 24 | $917.1M | $561.5M | ||
| Q2 24 | $889.0M | $548.2M |
负债/权益比APOGAXSM
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $122.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 7.8% | — |
| 现金转化率经营现金流/净利润 | 7.37× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流APOGAXSM
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $-18.7M | ||
| Q3 25 | $57.1M | $1.0M | ||
| Q2 25 | $-19.8M | $-32.4M | ||
| Q1 25 | $30.0M | $-43.4M | ||
| Q4 24 | $31.0M | $-26.2M | ||
| Q3 24 | $58.7M | $-18.6M | ||
| Q2 24 | $5.5M | $-30.1M |
自由现金流APOGAXSM
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | $-18.7M | ||
| Q3 25 | $52.4M | $988.0K | ||
| Q2 25 | $-26.9M | $-32.4M | ||
| Q1 25 | $19.1M | $-43.7M | ||
| Q4 24 | $22.0M | $-26.2M | ||
| Q3 24 | $50.2M | $-18.7M | ||
| Q2 24 | $-1.8M | $-30.2M |
自由现金流率APOGAXSM
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | -9.6% | ||
| Q3 25 | 14.6% | 0.6% | ||
| Q2 25 | -7.8% | -21.6% | ||
| Q1 25 | 5.5% | -36.0% | ||
| Q4 24 | 6.4% | -22.1% | ||
| Q3 24 | 14.7% | -17.9% | ||
| Q2 24 | -0.5% | -34.6% |
资本支出强度APOGAXSM
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 2.1% | 0.0% | ||
| Q1 25 | 3.2% | 0.3% | ||
| Q4 24 | 2.6% | 0.0% | ||
| Q3 24 | 2.5% | 0.1% | ||
| Q2 24 | 2.2% | 0.1% |
现金转化率APOGAXSM
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.08× | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.92× | — | ||
| Q2 24 | 0.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
